Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves

Cancer Res Treat. 2018;50(4):1226-1237. Published online December 28, 2017 DOI: https://doi.org/10.4143/crt.2017.446

Web of Science 9 Crossref 7

Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results

Yeon Hee Park, Tae Yong Kim, Young-Hyuck Im, Keun-Seok Lee, In Hae Park, Joohyuk Sohn, Soo-Hyeon Lee, Seock-Ah Im, Jee Hyun Kim, Se Hyun Kim, Soo Jung Lee, Su-Jin Koh, Ki Hyeong Lee, Yoon Ji Choi, Eun Kyung Cho, Suee Lee, Seok Yun Kang, Jae Hong Seo, Sung-Bae Kim, Kyung Hae Jung

Cancer Res Treat. 2017;49(2):423-429. Published online August 3, 2016 DOI: https://doi.org/10.4143/crt.2016.191

Web of Science 6 Crossref 8

A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets

Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer

Cancer Res Treat. 2016;48(3):1120-1129. Published online February 12, 2016 DOI: https://doi.org/10.4143/crt.2015.436

Web of Science 8 Crossref 8

Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor

Kwonoh Park, Jae-Lyun Lee, Jin-Hee Ahn, Kyoo Hyung Lee, In-Gab Jeong, Cheryn Song, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn

Cancer Res Treat. 2014;46(4):339-347. Published online July 16, 2014 DOI: https://doi.org/10.4143/crt.2013.154

Web of Science 5 Crossref 2

Metronomic S1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

Yi-Feng Yu, Peng Wu, Rui Zhuo, San-Gang Wu

Received December 20, 2023 Accepted February 18, 2024 Published online February 19, 2024
DOI: https://doi.org/10.4143/crt.2023.1343
[Accepted]

Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410 FAX: +82-2-792-1410 E-mail: journal@cancer.or.kr

About | Browse Articles | Current Issue | For Authors and Reviewers